Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma

Oncology Letters

Volumn 10, Issue 1, 2015, Pages 34-42

  Zhang, Mengzhen ^a   Xu, Liwei ^a   Wang, Xiaoling ^a   Sun, Beibei ^a   Ding, Juan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Dipeptidyl peptidase IV; Ovarian carcinoma; Seprase

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; MESSENGER RNA; SEPRASE;

ADULT; ARTICLE; BENIGN TUMOR; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CARCINOMA; PATHOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84929918914     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3151     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A and Hartmann LC: Current management strategies for ovarian cancer. Mayo Clin Proc 82: 751-770, 2007.
3. Morrison J: Advances in the understanding and treatment of ovarian cancer. J Br Menopause Soc 11: 66-71, 2005.
4. Bakrin N, Bereder JM, Decullier E, Classe JM, et al; FROGHI (French Oncologic and Gynecologic HIPEC) Group: Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39: 1435-1443, 2013.
5. Coleman RL, Monk BJ, Sood AK and Herzog TJ: Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol 10: 211-224, 2013.
6. Werb Z: ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-442, 1997.
7. Talvensaari-Mattila A, Santala M, Soini Y and Turpeenniemi-Hujanen T: Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. Anticancer Res 25: 4101-4105, 2005.
8. Rowe RG and Weiss SJ: Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu Rev Cell Dev Biol 25: 567-595, 2009.
9. Deakin NE and Chaplain MA: Mathematical modeling of cancer invasion: the role of membrane-bound matrix metalloproteinases. Front Oncol 3: 70, 2013.
10. Chen WT, Kelly T and Ghersi G: DPPIV, seprase and related serine peptidases in multiple cellular functions. Curr Top Dev Biol 54: 207-232, 2003.
11. Goscinski MA, Suo ZH, Nesland JM, Flørenes VA and Giercksky KE: Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines. APMIS 116: 823-831, 2008.
12. Mentlein R, Hattermann K, Hemion C, Jungbluth AA and Held-Feindt J: Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors. Biol Chem 392: 199-207, 2011.
13. Benedet JL, Bender H, Jones H III, Ngan HY and Pecorelli S: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209-262, 2000.
14. Wu Q, Suo Z, Risbegr B, Karlsson MG, Villman K and Nesland JM: Expression of EPhb2 And Ephb4 in Berast Caerinoma. Phatol oneol Res 10: 26-33, 2004.
15. Lawrie LC, Curran S, MeLeod HL, Fothergill JE and Murray GI: Applieation of laser capture microdissection And porteomics in colon cancer. Mol Pathol 54: 253-258, 2001.
16. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC and Chen WT: A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 54: 5702-5710, 1994.
17. Chen WT and Kelly T: Seprase complexes in cellular invasiveness. Cancer Metastasis Rev 22: 259-269, 2003.
18. Kotacková L, Baláziová E and Sedo A: Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer. Folia Biol (Praha) 55: 77-84, 2009.
19. Pro B and Dang NH: CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol 19: 1345-1351, 2004.
20. Mueller SC, Ghersi G, Akiyama SK, Sang QX, Howard L, Pineiro-Sanchez M, et al: A novel protease-docking function of integrin at invadopodia. J Biol Chem 274: 24947-24952, 1999.
21. O'Brien P and O'Connor BF: Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 1784: 1130-1145, 2008.
22. Kelly T, Kechelava S, Rozypal TL, West KW and Korourian S: Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol 11: 855-863, 1998.
23. Jin X, Iwasa S, Okada K, Mitsumata M and Ooi A: Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. Anticancer Res 23: 3195-3198, 2003.
24. Okada K, Chen WT, Iwasa S, Jin X, Yamane T, Ooi A and Mitsumata M: Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology 65: 363-370, 2003.
25. Wikberg ML, Edin S, Lundberg IV, Van Guelpen B, Dahlin AM, Rutegård J, et al: High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumour Biol 34: 1013-1020, 2013.
26. Huang Y, Wang S and Kelly T: Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res 64: 2712-2716, 2004.
27. Ariga N, Sato E, Ohuchi N, Nagura H and Ohtani H: Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer 95: 67-72, 2001.
28. Wilson MJ, Ruhland AR, Quast BJ, Reddy PK, Ewing SL and Sinha AA: Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl 21: 220-226, 2000.
29. Khin EE, Kikkawa F, Ino K, Kajiyama H, Suzuki T, Shibata K, et al: Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade. Am J Obstet Gynecol 188: 670-676, 2003.
30. Mizokami Y, Kajiyama H, Shibata K, Ino K, Kikkawa F and Mizutani S: Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. Int J Cancer 110: 652-659, 2004.
31. Abe M, Havre PA, Urasaki Y, Ohnuma K, Morimoto C, Dang LH and Dang NH: Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines. BMC Cancer 11: 51, 2011.
32. Miyake Y, Aratake Y, Sakaguchi T, Kiyoya K, Kuribayashi T, Marutsuka K and Ohno E: Examination of CD26/DPPIV, p53 and PTEN expression in thyroid follicular adenoma. Diagn Cytopathol 40: 1047-1053, 2012.
33. Kajiyama H, Kikkawa F, Suzuki T, Shibata K, Ino K and Mizutani S: Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res 62: 2753-2757, 2002.
34. Kennedy A, Dong H, Chen D and Chen WT: Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells. Int J Cancer 124: 27-35, 2009.
35. Lai D, Ma L and Wang F: Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Int J Oncol 41: 541-550, 2012.
36. Yang L, Ma L and Lai D: Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 45: 928-937, 2013.